Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2014
06/11/2014CN102512497B Extracting method for active ingredients of red-rooted salvia root medicinal material
06/11/2014CN102405052B Composition comprising the purified extract of bee venom for preventing and treating degenerative brain diseases
06/11/2014CN102333781B Tricyclic pyrazolopyrimidine derivative
06/11/2014CN102333762B Ethanamine compounds and application for treating depression
06/11/2014CN102267989B 2-methyl-benzofuran compounds and preparation and application thereof
06/11/2014CN102124006B Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
06/11/2014CN102066356B Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
06/11/2014CN102058888B Pharmaceutical composition for treatment of abnormal energy metabolism and application thereof
06/11/2014CN101838202B Total terpenoids of ferula dissecta as well as medical application and preparation method thereof
06/11/2014CN101742994B Telomerase activating compounds and methods of use thereof
06/11/2014CN101595100B Heterocyclic-substituted piperidine as orl-1 ligands
06/10/2014US8748600 Cyclic triazo sodium channel blockers
06/10/2014US8748599 Cyclic triazo sodium channel blockers
06/10/2014US8748564 Oxytocin receptor agonists
06/10/2014US8748459 Pyridinoylpiperidines as 5-HT1F agonists
06/10/2014US8748422 Pharmaceutical compositions containing quinazoline derivatives for treating as serotonin receptor antagonist
06/10/2014US8748367 Use of antisecretory factor
06/10/2014US8747924 Methods for preventing and treating neurodegenerative diseases
06/10/2014US8747889 Transdermal analgesic systems with reduced abuse potential
06/10/2014CA2795080C Purine compounds
06/10/2014CA2771189C Novel dihydro-oxazolobenzodiazepinon derivatives, processes for their preparation and pharmaceutical compositions containing them
06/10/2014CA2721815C Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
06/10/2014CA2634056C Amorphous form of 1,2-dihydropyridine compound
06/10/2014CA2612090C Tablet containing hardly soluble active ingredient
06/10/2014CA2605759C Antibodies directed against amyloid-beta peptide and methods using same
06/10/2014CA2559740C Thiadiazolidinones as gsk-3 inhibitors
06/10/2014CA2399280C Defects in periaxin associated with myelinopathies
06/05/2014WO2014085668A1 Anticonvulsant activity of steroids
06/05/2014WO2014085600A1 Neuroprotective agents for treatment of neurodegenerative diseases
06/05/2014WO2014085413A1 Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators
06/05/2014WO2014085367A1 Substituted benztropine analogs for treatment of dementia
06/05/2014WO2014085362A1 Methods for the treatment of parkinson's disease psychosis using pimavanserin
06/05/2014WO2014085284A1 Triazolo-pyrazine derivatives useful in the treatment of disorders of the central nervous system
06/05/2014WO2014085153A1 6-((s)-1-{1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl}- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist
06/05/2014WO2014084744A1 Saccharide dendritic cluster compounds as inhibitors of bace-1
06/05/2014WO2014084616A1 Pharmaceutical composition containing sceptridium japonicum extract for preventing or treating stroke or degenerative brain diseases
06/05/2014WO2014084460A1 Composition comprising acanthopanax koreanum extract as active ingredient for preventing or treating neuropsychiatric disorders
06/05/2014WO2014084401A1 Medical patch
06/05/2014WO2014084311A1 Ropinirole-containing adhesive patch
06/05/2014WO2014084085A1 Prophylactic/therapeutic agent for hearing disorder or cerebellar ataxia
06/05/2014WO2014083522A1 Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia
06/05/2014WO2014083327A1 Adenine derivatives suitable for the treatment of (inter alia) muscular dystrophy
06/05/2014WO2014083107A1 METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF
06/05/2014WO2014083071A1 Injectable liquid formulation of the combination of tramadol and paracetamol
06/05/2014WO2014083068A1 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone
06/05/2014WO2014083003A1 Pro-cognitive compound
06/05/2014WO2014082739A1 Substituted amino-arylcarboxamides as kcnq2/3 modulators
06/05/2014WO2014082738A1 Heteroquinoline-3-carboxamides as kcnq2/3 modulators
06/05/2014WO2014082737A1 Specific carboxamides as kcnq2/3 modulators
06/05/2014WO2014082548A1 2-aryl selenazole compound and pharmaceutical composition thereof
06/05/2014WO2014082514A1 Method for initiating stem cells of mammals and use of chlorine dioxide in preparation of drug for initiating stem cells of mammals
06/05/2014US20140155579 Dual specificity antibodies and methods of making and using
06/05/2014US20140154772 Inhibitors of human phosphatidylinositol 3-kinase delta
06/05/2014US20140154259 Method for the treatment of inflammatory disorders
06/05/2014US20140154216 Virus strains
06/05/2014US20140154215 Herpes virus strains
06/04/2014EP2737905A1 Use of g-csf dimer in preparation of medicament for treatment of neurodegenerative diseases
06/04/2014EP2737904A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
06/04/2014EP2737901A1 Therapeutic Use of Compounds
06/04/2014EP2736919A2 NOVEL 17ß-HETEROARYL-SUBSTITUTED STEROIDS AS MODULATORS OF GABAA RECEPTORS
06/04/2014EP2736908A1 Bicyclic pyrimidone compounds
06/04/2014EP2736902A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
06/04/2014EP2736900A1 Substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands
06/04/2014EP2736899A1 Substituted bicyclic aromatic carboxamide and urea derivatives as vanilloid receptor ligands
06/04/2014EP2736898A1 5ht1a antagonist useful for in vivo imaging
06/04/2014EP2736896A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
06/04/2014EP2736890A1 Cysteine prodrugs
06/04/2014EP2736888A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
06/04/2014EP2736882A1 Substituted heterocyclic aza derivatives
06/04/2014EP2736507A1 Basic alpha lipoic acid solution and its uses
06/04/2014EP2736501A1 Intrathecal or epidural administration of 3-[(1s,2s)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
06/04/2014CN103842357A Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands
06/04/2014CN103842356A 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
06/04/2014CN103841985A Agent for improving quality of sleep
06/04/2014CN103841966A Method for treating schizophrenia
06/04/2014CN103834541A Aralia mandshurica wine for tonifying blood and nourishing heart and production method thereof
06/04/2014CN103834540A Wintercherry heart-strengthening brain-nourishing wine and production method thereof
06/04/2014CN103834531A Nondrinking wine and preparation method thereof
06/04/2014CN103834003A New compound containing xalkori structure, preparation method thereof and application
06/04/2014CN103833998A Novel compound with ethacrynic acid structure as well as preparation method and application of novel compound
06/04/2014CN103833997A New compound with tozasertib structure as well as preparation method and application thereof
06/04/2014CN103833869A Costustoot sulphated polysaccharide as well as preparation method and application thereof
06/04/2014CN103833759A Pteridinone derivatives as BLK and FLT3 inhibitors and applications thereof
06/04/2014CN103833756A Pyridazinone compound as well as preparation method and application thereof
06/04/2014CN103833753A Alkynyl compound and its use method and purpose
06/04/2014CN103833728A Compound applicable to anesthetics
06/04/2014CN103833657A Compound crystal applicable to anesthetics
06/04/2014CN103833654A Compound crystal applicable to anesthetics
06/04/2014CN103833653A Compound crystal applicable to anesthetics
06/04/2014CN103833647A Compound applicable to anesthetics
06/04/2014CN103833640A Edaravone crystal, preparation method and application thereof
06/04/2014CN103833630A Deuterated CFTR (Cystic Fibrosis Transmembrane Regulator) synergist
06/04/2014CN103833627A Compound applicable to anesthetics
06/04/2014CN103833564A L-ornithine glutamic acid double salt and preparation method and application thereof
06/04/2014CN103833544A 11-beta-hydroxysteroid dehydrogenase type i inhibitors
06/04/2014CN103830719A Methods for performing coronary artery bypass graft procedure
06/04/2014CN103830716A Traditional Chinese medicine preparation with effects of refreshing and restoring consciousness, removing stasis to generate new cells, generating hair and protecting brain
06/04/2014CN103830710A Traditional Chinese medicine for treating manic-depressive psychosis and preparation method thereof
06/04/2014CN103830701A Traditional Chinese medicine for treating insomnia caused by worry beyond measure
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 1833